United States RNA Drugs Market Report 2017

August 2017 | 112 pages | ID: UA51FF47604EN
QYResearch

Abstracts

In this report, the United States RNA Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of RNA Drugs in these regions, from 2012 to 2022 (forecast).

United States RNA Drugs market competition by top manufacturers/players, with RNA Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• siRNA
• ASO
• miRNA
• Nucleic Acid Aptamers

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of RNA Drugs for each application, including

• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States RNA Drugs Market Report 2017

1 RNA DRUGS OVERVIEW

1.1 Product Overview and Scope of RNA Drugs
1.2 Classification of RNA Drugs by Product Category
  1.2.1 United States RNA Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States RNA Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 siRNA
  1.2.4 ASO
  1.2.5 miRNA
  1.2.6 Nucleic Acid Aptamers
1.3 United States RNA Drugs Market by Application/End Users
  1.3.1 United States RNA Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 United States RNA Drugs Market by Region
  1.4.1 United States RNA Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West RNA Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest RNA Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic RNA Drugs Status and Prospect (2012-2022)
  1.4.5 New England RNA Drugs Status and Prospect (2012-2022)
  1.4.6 The South RNA Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest RNA Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of RNA Drugs (2012-2022)
  1.5.1 United States RNA Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States RNA Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES RNA DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States RNA Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States RNA Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States RNA Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States RNA Drugs Market Competitive Situation and Trends
  2.4.1 United States RNA Drugs Market Concentration Rate
  2.4.2 United States RNA Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers RNA Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RNA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States RNA Drugs Sales and Market Share by Region (2012-2017)
3.2 United States RNA Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States RNA Drugs Price by Region (2012-2017)

4 UNITED STATES RNA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States RNA Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States RNA Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States RNA Drugs Price by Type (2012-2017)
4.4 United States RNA Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RNA DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States RNA Drugs Sales and Market Share by Application (2012-2017)
5.2 United States RNA Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RNA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 RNA Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 RNA Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi-Aventis
  6.3.2 RNA Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.2 RNA Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Arrowhead Pharmaceuticals
  6.5.2 RNA Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Benitec Biopharma
  6.6.2 RNA Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Calimmune Inc
  6.7.2 RNA Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Dicerna
  6.8.2 RNA Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gradalis
  6.9.2 RNA Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Quark
  6.10.2 RNA Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 RXi
6.12 Senesco
6.13 Silence Therapeutics
6.14 Silenseed
6.15 Tekmira
6.16 Alnylam Pharmaceuticals

7 RNA DRUGS MANUFACTURING COST ANALYSIS

7.1 RNA Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of RNA Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 RNA Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of RNA Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RNA DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States RNA Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States RNA Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States RNA Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States RNA Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of RNA Drugs
Figure United States RNA Drugs Market Size (K Units) by Type (2012-2022)
Figure United States RNA Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure siRNA Product Picture
Figure ASO Product Picture
Figure miRNA Product Picture
Figure Nucleic Acid Aptamers Product Picture
Figure United States RNA Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of RNA Drugs by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States RNA Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States RNA Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States RNA Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States RNA Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States RNA Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States RNA Drugs Sales Share by Players/Suppliers
Figure 2017 United States RNA Drugs Sales Share by Players/Suppliers
Figure United States RNA Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States RNA Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States RNA Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States RNA Drugs Revenue Share by Players/Suppliers
Figure 2017 United States RNA Drugs Revenue Share by Players/Suppliers
Table United States Market RNA Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market RNA Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States RNA Drugs Market Share of Top 3 Players/Suppliers
Figure United States RNA Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers RNA Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers RNA Drugs Product Category
Table United States RNA Drugs Sales (K Units) by Region (2012-2017)
Table United States RNA Drugs Sales Share by Region (2012-2017)
Figure United States RNA Drugs Sales Share by Region (2012-2017)
Figure United States RNA Drugs Sales Market Share by Region in 2016
Table United States RNA Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States RNA Drugs Revenue Share by Region (2012-2017)
Figure United States RNA Drugs Revenue Market Share by Region (2012-2017)
Figure United States RNA Drugs Revenue Market Share by Region in 2016
Table United States RNA Drugs Price (USD/Unit) by Region (2012-2017)
Table United States RNA Drugs Sales (K Units) by Type (2012-2017)
Table United States RNA Drugs Sales Share by Type (2012-2017)
Figure United States RNA Drugs Sales Share by Type (2012-2017)
Figure United States RNA Drugs Sales Market Share by Type in 2016
Table United States RNA Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States RNA Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA Drugs by Type (2012-2017)
Figure Revenue Market Share of RNA Drugs by Type in 2016
Table United States RNA Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States RNA Drugs Sales Growth Rate by Type (2012-2017)
Table United States RNA Drugs Sales (K Units) by Application (2012-2017)
Table United States RNA Drugs Sales Market Share by Application (2012-2017)
Figure United States RNA Drugs Sales Market Share by Application (2012-2017)
Figure United States RNA Drugs Sales Market Share by Application in 2016
Table United States RNA Drugs Sales Growth Rate by Application (2012-2017)
Figure United States RNA Drugs Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA Drugs Sales Growth Rate (2012-2017)
Figure Pfizer RNA Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer RNA Drugs Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA Drugs Sales Growth Rate (2012-2017)
Figure Roche RNA Drugs Sales Market Share in United States (2012-2017)
Figure Roche RNA Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA Drugs Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis RNA Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories RNA Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories RNA Drugs Revenue Market Share in United States (2012-2017)
Table Arrowhead Pharmaceuticals Basic Information List
Table Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Sales Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Sales Market Share in United States (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Revenue Market Share in United States (2012-2017)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA Drugs Sales Growth Rate (2012-2017)
Figure Benitec Biopharma RNA Drugs Sales Market Share in United States (2012-2017)
Figure Benitec Biopharma RNA Drugs Revenue Market Share in United States (2012-2017)
Table Calimmune Inc Basic Information List
Table Calimmune Inc RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA Drugs Sales Growth Rate (2012-2017)
Figure Calimmune Inc RNA Drugs Sales Market Share in United States (2012-2017)
Figure Calimmune Inc RNA Drugs Revenue Market Share in United States (2012-2017)
Table Dicerna Basic Information List
Table Dicerna RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA Drugs Sales Growth Rate (2012-2017)
Figure Dicerna RNA Drugs Sales Market Share in United States (2012-2017)
Figure Dicerna RNA Drugs Revenue Market Share in United States (2012-2017)
Table Gradalis Basic Information List
Table Gradalis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA Drugs Sales Growth Rate (2012-2017)
Figure Gradalis RNA Drugs Sales Market Share in United States (2012-2017)
Figure Gradalis RNA Drugs Revenue Market Share in United States (2012-2017)
Table Quark Basic Information List
Table Quark RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA Drugs Sales Growth Rate (2012-2017)
Figure Quark RNA Drugs Sales Market Share in United States (2012-2017)
Figure Quark RNA Drugs Revenue Market Share in United States (2012-2017)
Table RXi Basic Information List
Table Senesco Basic Information List
Table Silence Therapeutics Basic Information List
Table Silenseed Basic Information List
Table Tekmira Basic Information List
Table Alnylam Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Drugs
Figure Manufacturing Process Analysis of RNA Drugs
Figure RNA Drugs Industrial Chain Analysis
Table Raw Materials Sources of RNA Drugs Major Players/Suppliers in 2016
Table Major Buyers of RNA Drugs
Table Distributors/Traders List
Figure United States RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States RNA Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States RNA Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States RNA Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States RNA Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States RNA Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States RNA Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States RNA Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States RNA Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States RNA Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States RNA Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States RNA Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources